| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
10,651 |
8,790 |
$382K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
4,653 |
3,976 |
$275K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
246 |
216 |
$54K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,736 |
1,467 |
$49K |
| 80053 |
Comprehensive metabolic panel |
4,459 |
3,767 |
$47K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,829 |
4,057 |
$41K |
| 87276 |
|
2,651 |
2,308 |
$41K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,488 |
2,217 |
$38K |
| 87275 |
|
2,944 |
2,573 |
$34K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
712 |
614 |
$32K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,444 |
1,301 |
$24K |
| 71046 |
Radiologic examination, chest; 2 views |
1,296 |
1,125 |
$13K |
| 80061 |
Lipid panel |
775 |
713 |
$12K |
| 84439 |
|
1,194 |
1,065 |
$11K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
284 |
248 |
$10K |
| 87070 |
|
648 |
591 |
$8K |
| 81001 |
|
1,428 |
1,181 |
$4K |
| 87420 |
|
270 |
237 |
$4K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
124 |
91 |
$4K |
| 82607 |
|
186 |
182 |
$3K |
| 83655 |
|
219 |
194 |
$3K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
128 |
117 |
$3K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
285 |
220 |
$3K |
| 99001 |
|
712 |
660 |
$3K |
| 83735 |
|
449 |
352 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
174 |
157 |
$3K |
| 81000 |
|
761 |
530 |
$2K |
| 84466 |
|
116 |
114 |
$2K |
| 87428 |
|
43 |
38 |
$2K |
| 70450 |
Computed tomography, head or brain; without contrast material |
29 |
24 |
$2K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
28 |
25 |
$2K |
| 82746 |
|
115 |
113 |
$2K |
| 82728 |
|
115 |
113 |
$1K |
| 81025 |
|
363 |
321 |
$1K |
| 0011A |
|
33 |
26 |
$1K |
| 81003 |
|
327 |
305 |
$855.40 |
| 83540 |
|
116 |
114 |
$850.30 |
| 85045 |
|
115 |
113 |
$637.20 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
74 |
73 |
$583.70 |
| 86077 |
|
15 |
13 |
$521.95 |
| 82550 |
|
58 |
56 |
$480.00 |
| 85014 |
|
165 |
144 |
$475.39 |
| 85018 |
|
165 |
143 |
$468.45 |
| 0012A |
|
13 |
12 |
$440.00 |
| 74022 |
|
15 |
13 |
$304.44 |
| 83690 |
|
46 |
40 |
$250.48 |
| 82150 |
|
46 |
40 |
$242.10 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
14 |
13 |
$160.60 |
| 85660 |
|
29 |
27 |
$139.62 |
| 86140 |
|
46 |
42 |
$97.68 |
| 85027 |
|
14 |
12 |
$77.99 |
| 85651 |
|
15 |
14 |
$73.08 |
| 36415 |
Collection of venous blood by venipuncture |
3,321 |
2,753 |
$48.96 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
14 |
13 |
$25.92 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
60 |
52 |
$8.19 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
36 |
30 |
$3.25 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
30 |
28 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
825 |
628 |
$0.00 |
| 91301 |
|
69 |
55 |
$0.00 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
721 |
657 |
$0.00 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
26 |
20 |
$0.00 |